AMA responds to administration blueprint to tackle rising drug prices

| 1 Min Read

CHICAGO — The American Medical Association (AMA) sent the following letter in response to the Trump Administration’s request for comments to its plan to lower drug prices. The letter from AMA CEO and Executive Vice President James L. Madara, M.D., was sent to Health and Human Services Secretary Alex M. Azar II.

 

 

 

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Patient in hospital bed

Nurse practitioners’ care linked to 11% longer stays in the ED

| 4 Min Read
Two healthcare workers in conversation

Mid-career physicians report higher burnout rates

| 6 Min Read
Patient in a wheelchair

Shape your state’s hardship exemptions to Medicaid work requirements

| 7 Min Read
Doctor with reassuring hand on smiling patient

What doctors want patients to know about lupus

| 13 Min Read